» Articles » PMID: 17064834

High-sensitivity C-reactive Protein Levels in Patients with Major Depressive Disorder and Bipolar Mania

Overview
Specialty Psychiatry
Date 2006 Oct 27
PMID 17064834
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The serum high-sensitivity C-reactive protein (hsCRP) levels in patients with major depressive disorder and bipolar I disorder in acute phases were investigated. During a 1-year period, a total of 67 participants including 23 patients with major depressive disorder, 13 patients with bipolar I disorder (manic episode) and 31 healthy controls were recruited in this study. The diagnoses of mental disorders in participants were made by one psychiatrist according to the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID). Both patient groups with major depression and bipolar disorder had higher mean serum hsCRP levels than the healthy control group. Using analysis of covariance with age adjustment, patients with bipolar I disorders still had significantly higher hsCRP levels than healthy controls (P=0.043). However, patients with major depression did not have significantly higher hsCRP levels than healthy controls (P=0.172). These results suggest that patients with bipolar I disorder might have a more severe inflammation reaction than patients without major depression. However, larger samples and adequate statistical methods are needed to prove these results.

Citing Articles

Brain-derived Neurotrophic Factor and High Sensitive C-reactive Protein in Bipolar Depression and Unipolar Depression: The Practical Usage as a Discriminatory Tool.

Shahyad S, Kheirabadi G, Pirzad Jahromi G, Massaly M Clin Psychopharmacol Neurosci. 2023; 21(1):108-117.

PMID: 36700317 PMC: 9889908. DOI: 10.9758/cpn.2023.21.1.108.


Neutrophil-to-Lymphocyte, Monocyte-to-Lymphocyte, Platelet-to-Lymphocyte Ratio and Systemic Immune-Inflammatory Index in Different States of Bipolar Disorder.

Dadouli K, Janho M, Hatziefthimiou A, Voulgaridi I, Piaha K, Anagnostopoulos L Brain Sci. 2022; 12(8).

PMID: 36009097 PMC: 9405738. DOI: 10.3390/brainsci12081034.


Roles of C-reactive protein polymorphisms and life event changes on cognitive function in bipolar patients receiving valproate.

Chen P, Tang L, Chang H Int J Immunopathol Pharmacol. 2022; 36:3946320221084835.

PMID: 35377256 PMC: 8984865. DOI: 10.1177/03946320221084835.


C-Reactive Protein as a Biomarker for Major Depressive Disorder?.

Orsolini L, Pompili S, Tempia Valenta S, Salvi V, Volpe U Int J Mol Sci. 2022; 23(3).

PMID: 35163538 PMC: 8836046. DOI: 10.3390/ijms23031616.


Inflammatory signaling mechanisms in bipolar disorder.

Jones G, Vecera C, Pinjari O, Machado-Vieira R J Biomed Sci. 2021; 28(1):45.

PMID: 34112182 PMC: 8194019. DOI: 10.1186/s12929-021-00742-6.